Total Payments
$652.36
2022 Payments
$50.53
Companies
16
Transactions
40
Medicare Patients
2,071
Medicare Billing
$303,584
Payment Breakdown by Category
Food & Beverage$652.36 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $652.36 | 40 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $97.49 | 7 | $0 (2021) |
| Allergan, Inc. | $75.97 | 4 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $63.11 | 4 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $58.37 | 4 | $0 (2020) |
| PORTOLA PHARMACEUTICALS, INC. | $50.20 | 2 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $45.94 | 3 | $0 (2020) |
| GlaxoSmithKline, LLC. | $45.13 | 2 | $0 (2019) |
| Mylan Specialty L.P. | $44.47 | 2 | $0 (2020) |
| Melinta Therapeutics, Inc. | $39.12 | 3 | $0 (2019) |
| Relypsa, Inc. | $34.20 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $50.53 | 3 | Janssen Pharmaceuticals, Inc ($50.53) |
| 2021 | $13.95 | 1 | PFIZER INC. ($13.95) |
| 2020 | $134.62 | 8 | Mylan Specialty L.P. ($44.47) |
| 2019 | $380.33 | 23 | PORTOLA PHARMACEUTICALS, INC. ($50.20) |
| 2018 | $40.91 | 3 | PFIZER INC. ($29.03) |
| 2017 | $32.02 | 2 | Allergan Inc. ($17.32) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/16/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/21/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/12/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/23/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/19/2020 | CHIESI USA, INC. | CLEVIPREX 25MG/50ML (Drug), CLEVIPREX 50MG/100ML, KENGREAL 50MG/10ML L | Food and Beverage | Cash or cash equivalent | $18.41 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/06/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/05/2020 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/06/2020 | bioMerieux | VIDAS BRAHMS PCT (Device) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Diagnostics | ||||||
| 02/06/2020 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/04/2020 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Respiratory and Allergy | ||||||
| 01/23/2020 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: Respiratory and Allergy | ||||||
| 01/22/2020 | Allergan, Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/15/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/12/2019 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/11/2019 | Melinta Therapeutics, Inc. | Baxdela (Drug) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: ANTIBIOTICS | ||||||
| 10/03/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Hyperkalemia | ||||||
| 10/02/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.53 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2019 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/29/2019 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/12/2019 | bioMerieux | VIDAS BRAHMS PCT (Device) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: Diagnostic | ||||||
| 07/24/2019 | Philips Electronics North America Corporation | Trilogy 100 (Device) | Food and Beverage | Cash or cash equivalent | $13.44 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 07/17/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/01/2019 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/26/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: RESPIRATORY | ||||||
| 06/25/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 515 | 824 | $325,166 | $75,071 |
| 2022 | 6 | 621 | 1,087 | $313,488 | $87,808 |
| 2021 | 5 | 565 | 982 | $287,225 | $84,036 |
| 2020 | 4 | 370 | 669 | $193,115 | $56,668 |
Total Patients
2,071
Total Services
3,562
Medicare Billing
$303,584
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 224 | 524 | $193,698 | $45,966 | 23.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 188 | 193 | $71,559 | $16,428 | 23.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 92 | 95 | $56,282 | $11,997 | 21.3% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 11 | 12 | $3,627 | $681.36 | 18.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 288 | 737 | $196,197 | $54,568 | 27.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 191 | 200 | $55,068 | $15,328 | 27.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 89 | 93 | $46,112 | $13,407 | 29.1% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 15 | 15 | $6,780 | $1,971 | 29.1% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 26 | 27 | $5,720 | $1,392 | 24.3% |
| 99226 | Follow-up observation care per day, typically 35 minutes | Facility | 2022 | 12 | 15 | $3,611 | $1,142 | 31.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 274 | 670 | $178,361 | $52,554 | 29.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 107 | 114 | $56,525 | $16,937 | 30.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 157 | 167 | $45,982 | $12,954 | 28.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 15 | 19 | $3,715 | $933.98 | 25.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 12 | 12 | $2,643 | $657.48 | 24.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 182 | 479 | $127,515 | $37,773 | 29.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 64 | 64 | $31,733 | $9,285 | 29.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 111 | 113 | $31,113 | $8,944 | 28.7% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 13 | 13 | $2,754 | $666.08 | 24.2% |
About Dr. Dawn Pingleton, D.O
Dr. Dawn Pingleton, D.O is a Hospitalist healthcare provider based in Paducah, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2007. The National Provider Identifier (NPI) number assigned to this provider is 1013100767.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dawn Pingleton, D.O has received a total of $652.36 in payments from pharmaceutical and medical device companies, with $50.53 received in 2022. These payments were reported across 40 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($652.36).
As a Medicare-enrolled provider, Pingleton has provided services to 2,071 Medicare beneficiaries, totaling 3,562 services with total Medicare billing of $303,584. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospitalist
- Other Specialties Internal Medicine
- Location Paducah, KY
- Active Since 08/24/2007
- Last Updated 12/17/2014
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1013100767
Products in Payments
- ELIQUIS (Drug) $95.50
- XARELTO (Drug) $63.11
- DIFICID (Drug) $58.37
- ANDEXXA (Biological) $50.20
- ENTRESTO (Drug) $45.94
- TRELEGY ELLIPTA (Drug) $45.13
- Yupelri (Drug) $44.47
- AVYCAZ (Drug) $38.06
- DALVANCE (Drug) $37.91
- Veltassa (Drug) $34.20
- Orbactiv (Drug) $27.84
- VIDAS BRAHMS PCT (Device) $26.28
- CLEVIPREX 25MG/50ML (Drug) $18.41
- LOKELMA (Drug) $15.04
- CHANTIX (Drug) $13.87
- Trilogy 100 (Device) $13.44
- LONHALA MAGNAIR (Drug) $13.31
- Baxdela (Drug) $11.28
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.